Boys Arnold & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,949
Closed -$489K 274
2019
Q3
$489K Sell
4,949
-155
-3% -$14.7K 0.07% 194
2019
Q2
$472K Sell
5,104
-175
-3% -$16.6K 0.07% 204
2019
Q1
$498K Sell
5,279
-2,917
-36% -$255K 0.07% 196
2018
Q4
$512K Sell
8,196
-1,429
-15% -$105K 0.08% 186
2018
Q3
$865K Sell
9,625
-1,979
-17% -$175K 0.12% 161
2018
Q2
$922K Sell
11,604
-3,378
-23% -$280K 0.13% 156
2018
Q1
$1.33M Sell
14,982
-3,204
-18% -$308K 0.19% 120
2017
Q4
$1.9M Sell
18,186
-3,874
-18% -$437K 0.29% 93
2017
Q3
$3.22M Sell
22,060
-238
-1% -$32.4K 0.51% 54
2017
Q2
$2.9M Buy
22,298
+716
+3% +$87.7K 0.37% 60
2017
Q1
$2.69M Buy
21,582
+729
+3% +$87.2K 0.42% 62
2016
Q4
$2.41M Sell
20,853
-572
-3% -$63.7K 0.4% 63
2016
Q3
$2.24M Sell
21,425
-284
-1% -$30.7K 0.38% 70
2016
Q2
$2.14M Buy
21,709
+10,044
+86% +$1.04M 0.37% 74
2016
Q1
$1.17M Sell
11,665
-30,827
-73% -$3.17M 0.46% 58
2015
Q4
$5.09M Buy
42,492
+22,213
+110% +$2.57M 0.55% 52
2015
Q3
$2.19M Sell
20,279
-265
-1% -$32.9K 0.46% 66
2015
Q2
$2.38M Buy
20,544
+1,615
+9% +$185K 0.46% 65
2015
Q1
$2.18M Buy
+18,929
New +$2.26M 0.42% 75

Other funds holding CELG

Boys Arnold & Co's CELG Position: Q4 2019 in Review

Boys Arnold & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,949 shares — an estimated $489K sold.

Boys Arnold & Co first reported a position in CELG in Q1 2015 and held it in 19 quarters. The position peaked at $5.09M in Q4 2015. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Boys Arnold & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Boys Arnold & Co sold 4,949 Celgene Corp shares in Q4 2019, an estimated $489K.
  • Boys Arnold & Co first reported a position in Celgene Corp in Q1 2015 and held it in 19 quarters.
  • Boys Arnold & Co's Celgene Corp position peaked at $5.09M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Boys Arnold & Co's 13F filing for Q4 2019, filed 30 Jan 2020.